Julia Stomper
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study.
Journal: European journal of haematology
Published: February 17, 2025
The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.
Journal: Blood cancer journal
Published: February 10, 2022
Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
Journal: Clinical epigenetics
Published: April 29, 2021
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.
Journal: Leukemia
Published: August 14, 2020
Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine.
Journal: British journal of haematology
Published: March 25, 2020
Can we predict responsiveness to hypomethylating agents in AML?
Journal: Seminars in hematology
Published: June 30, 2018
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.
Journal: Haematologica
Published: December 30, 2017
Landscape of chromosome number changes in prostate cancer progression.
Journal: World journal of urology
Published: January 10, 2013
Last Updated: 09/26/2026